Lantheus (LNTH) News
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
100.15+0.03 (+0.03%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 100.15 0.00%
LNTH news summary
We found 1 recent headline mentioning Lantheus (LNTH): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, LNTH is up 0.03% at $100.15. The most recent story, "New FDA Drug Approvals - August 2026", was published by Nasdaq on Sep 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology